Study guide
5.2 Judicious Use of Antimicrobials & High-Risk Agents
APC Intern Written Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Pathway to General Registration 1.3 Restricted Open-Book Strategy (AMH & APF) 1.4 Scoring, Results & Appeals
2 Legal Framework: PBS & Medicine Schedules
2.1 PBS, Authority Prescriptions & Special Access Scheme 2.2 Schedules 2 & 3 (Pharmacy & Pharmacist Only Medicines) 2.3 Schedules 4 & 8 (Prescription Only & Controlled Drugs)
3 Legal Framework: Privacy, National Law & Pharmacy Board
3.1 Privacy, Confidentiality & Patient Rights 3.2 Health Practitioner National Law & Registration 3.3 Pharmacy Board Codes, Guidelines & Standards
4 Patient-Centred Medication Management
4.1 Assessing Clinical Situations & Treatment Options 4.2 Patient Factors: Adherence, Efficacy & Safety 4.3 Drug & Dosage-Form Factors 4.4 Culturally Responsive Medication Management
5 Primary Care & Judicious Use of Medicines
5.1 Primary Care & OTC Assessment 5.2 Judicious Use of Antimicrobials & High-Risk Agents 5.3 Non-Pharmacological Options & Evidence-Based OTC Choices
6 Dispensing & Clinical Appropriateness
6.1 Prescription Evaluation 6.2 Clinical Appropriateness Checks 6.3 Labelling, Packaging & Dispensing Standards 6.4 Communicating with Prescribers & Documenting Changes
7 Counselling & Acute Care
7.1 Patient-Centred Counselling 7.2 Confirming Understanding & Lifestyle Counselling 7.3 Acute Illness, Injury & Emergency Response
8 Therapeutics: Cardiovascular & Endocrine
8.1 Hypertension & Heart Failure 8.2 Ischaemic Heart Disease & Anticoagulation 8.3 Diabetes Medicines 8.4 Thyroid & Lipid Disorders
9 Therapeutics: Infection, Respiratory & Gastrointestinal
9.1 Anti-Infectives & Infection Management 9.2 Asthma & COPD 9.3 Gastrointestinal & Hepatic Conditions 9.4 Vaccination & Travel Health
10 Therapeutics: Neurology, Psychiatry & Pain
10.1 Epilepsy & Movement Disorders 10.2 Depression, Anxiety & Psychosis 10.3 Pain Management & Opioids 10.4 Migraine & Common Analgesics
11 Therapeutics: Special Populations & Systems
11.1 Women's Health, Contraception & Pregnancy 11.2 Dermatology, Ophthalmology & ENT 11.3 Renal/Hepatic Impairment & Dose Adjustment
12 Therapeutics: Rheumatology, Haematology, Urology, Oncology & Toxicology
12.1 Rheumatology: Gout, Osteoarthritis & Inflammatory Arthritis 12.2 Haematology: Anaemias & Blood Safety Monitoring 12.3 Urology & Men's Health 12.4 Oncology Support & Oral Anticancer Medicines 12.5 Toxicology & Poisoning Management
13 Monitoring: Clinical Review
13.1 Clinical Review Process 13.2 Interpreting Laboratory & Clinical Monitoring 13.3 Recommending Treatment Modifications
14 Monitoring: Safety & Adverse Drug Reactions
14.1 Adverse Drug Reactions & Reporting 14.2 Allergies, Sensitivities & Cross-Reactivity 14.3 High-Risk Medicines Monitoring
15 Compounding Medicines
15.1 Determining Required Formulations 15.2 Compounding Standards & Quality 15.3 Patient-Specific Preparations
16 Pharmaceutical Calculations
16.1 Dosage Calculations 16.2 Concentrations, Dilutions & Alligation 16.3 Half-Life & Basic Kinetic Calculations
17 Promote Health & Well-Being
17.1 National & Local Health Priorities 17.2 Screening Programs & Pharmacist Role 17.3 Culturally Responsive Promotion & Self-Sufficiency
5.2 Judicious Use of Antimicrobials & High-Risk Agents
Key Takeaways Explain This Topic AI
Antimicrobial stewardship means the right drug, dose, route, and duration for a proven or highly likely bacterial indication — and no antibiotic when the illness is almost certainly viral and self-limiting.
Community pharmacists influence stewardship at supply, counselling, hospital-to-home transitions, and when patients request ‘something for infection’ without assessment.
Allergy history must separate true immune-mediated allergy (for example anaphylaxis, severe cutaneous reactions) from intolerance (nausea, mild rash of uncertain type) before labelling a patient ‘allergic’ and forcing unnecessarily broad alternatives.
High-risk agents such as methotrexate, warfarin, insulin, opioids, and oral chemotherapy require focused supply checks and counselling because small process failures cause major harm.
Judicious use also means avoiding unnecessary medicines of any class: duplicates, treatments without indication, and symptomatic polypharmacy that adds risk without benefit.
Last updated: August 2026
Judicious use as a clinical habit
Judicious use of medicines means every recommendation or supply should have a clear indication, a favourable benefit–harm balance for this patient, and a plan for duration and review. For antimicrobials the public health stakes are higher because unnecessary use drives resistance , Clostridioides difficile risk, adverse effects, and false reassurance that delays proper care. For high-risk non-antimicrobials the stakes are individual catastrophic harm: bleeding, hypoglycaemia, cytopenias, overdose, and preventable hospitalisation.
On the APC Intern Written Examination, expect scenarios that reward restraint with reasons , not automatic product supply. AMH remains your dosing, interaction, and caution reference; APF supports counselling standards and cautionary labels.
Antimicrobial stewardship in community and transition care
Australian stewardship principles align with national quality use of medicines and hospital programs (for example antimicrobial stewardship frameworks used in accredited health services). In community pharmacy your levers include:
- Not promoting antibiotics for typical viral upper respiratory tract infections
- Explaining expected illness duration (for example many colds last 7–10 days; cough may persist longer)
Supporting symptomatic care: fluids, rest, analgesia/antipyretic when appropriate, saline, honey in eligible children/adults, inhaler technique for reactive airways
Checking that prescribed antibiotics match indication, dose, renal function, allergies, and interactions
Encouraging completion of the prescribed course as directed by the prescriber/AMH regimen while also understanding that modern practice sometimes uses shorter evidence-based durations — do not invent shorter or longer courses yourself
Flagging duplicate therapy (two agents from the same class without rationale)
Supporting hospital discharge antibiotic plans: what changed, how long left, monitoring for allergy or severe diarrhoea, and when to seek review
At the hospital–community interface, reconciliation errors are common: antibiotic stopped in hospital but still listed on an old token; long-term prophylaxis continued unintentionally; or IV-to-oral switch counselling incomplete. Pharmacists who clarify the plan reduce both under-treatment and unnecessary exposure.
Viral versus bacterial presentations — reasoning, not slogans
Many patients believe coloured sputum, green mucus, or “feeling wretched” proves bacterial infection. Teach a more accurate frame:
Feature more consistent with viral/self-limiting illness Features that raise bacterial or complicated infection concern
Gradual onset coryza, sore throat, dry or productive cough without red flags High fever with focal findings (for example suspected pneumonia), severe unilateral facial pain with purulent discharge and prolonged course, cellulitis with spreading erythema
Multiple household contacts with similar cold symptoms Immunocompromise, significant chronic disease decompensation
Illness day 2–4 of a typical cold Symptoms markedly worsening after initial improvement (sometimes “double sickening”)
Normal hydration and activity relatively preserved Systemic toxicity, confusion, severe dehydration, suspected sepsis
Streptococcal sore throat , urinary tract infection, cellulitis, otitis media in selected ages, sexually transmitted infections, and true pneumonia are examples where antibacterials may be indicated — usually after clinical (and sometimes laboratory) assessment by an appropriate prescriber. Your job in primary care is often to triage and educate , not to invent a diagnosis to justify a non-prescription “antibiotic alternative” that is actually just another symptomatic product sold with false certainty.
Never recommend leftover antibiotics from a previous illness. Never endorse sharing antibiotics between family members. Both practices are unsafe and undermine stewardship.
Spectrum, duration, and “stronger” antibiotics
Stewardship prefers:
- Narrowest effective spectrum for the likely pathogen and site
- Adequate dose for site penetration and patient factors (weight, renal function)
- Appropriate route (oral when bioavailability and severity allow)
- Shortest effective duration supported by guidelines and the prescriber’s plan
“Stronger” is not a clinical category. A broad-spectrum agent is not better for a simple infection; it may be worse because of collateral damage to normal flora and resistance pressure. If a prescription appears mismatched (for example a reserve broad-spectrum oral agent for a minor self-limiting complaint without explanation), contact the prescriber professionally rather than silently dispensing and hoping.
Watch for drug–bug mismatch clues in exam vignettes: antibiotic historically inactive for the likely organism, inadequate UTI agent in pregnancy, or macrolide use without considering interactions (for example QT risk or CYP interactions with certain long-term medicines).
Allergy history: true allergy versus intolerance
A chart label saying “penicillin allergy” is not a complete clinical story. Clarify:
What drug exactly (penicillin V, amoxicillin, flucloxacillin, cephalexin, unknown “penicillin”)?
What happened (timing, rash type, swelling, breathing difficulty, anaphylaxis, severe skin reaction such as SJS/TEN, organ involvement)?
How long ago , and any later tolerated related antibiotics?
Was it predictable intolerance (nausea, diarrhoea, thrush, headache) rather than immune-mediated allergy?
Why this matters:
Patients labelled allergic often receive broader, more toxic, or less effective alternatives.
Some reported childhood rashes were viral exanthems coinciding with antibiotic use.
Severe true allergies (anaphylaxis, severe cutaneous adverse reactions) require strict avoidance and emergency planning; trivial GI upset does not justify the same restrictions.
Document the clarified history and communicate material updates to the care team. Do not remove a serious allergy label casually, and do not ignore anaphylaxis history to “just try a course.” Cross-reactivity reasoning (for example some cephalosporins and penicillin history) is nuanced — use AMH and specialist guidance rather than absolute folk rules.
High-risk agents: supply checks and counselling focus
High-risk medicines deserve a slower, structured supply process even when legally the prescription is valid.
Methotrexate (weekly dosing disasters)
Confirm once-weekly dosing for usual rheumatology/dermatology regimens (not daily unless a specialist oncology context is explicit and verified).
Check folic acid co-therapy where used.
Counsel on infection risk, mouth ulcers, unexplained bruising, breathlessness, and need for blood monitoring as directed.
Watch interacting medicines (for example some antibiotics such as trimethoprim-containing products can be problematic — check AMH).
Ensure labelling and consumer warnings make the weekly schedule unmistakable.
Warfarin and other anticoagulants
For warfarin: INR monitoring plan, vitamin K consistency messaging without extreme diet myths, interacting antibiotics and NSAIDs, bleeding signs, and double-check dose changes after lab results.
For DOACs: renal function relevance, adherence criticality, interactions, and procedures/dental work communication.
Avoid adding OTC NSAIDs or high-dose fish oil casually without risk discussion.
Insulin
Confirm product identity (basal vs bolus; brand/device), dose, timing with food for mealtime insulins, and hypoglycaemia recognition/treatment.
Storage: in-use pens versus refrigerated stock.
Device technique and needle supply.
Sick-day thinking: when to seek advice if not eating or if glucose is high with ketones (as applicable to the patient’s plan).
Opioids
Check dose, formulation (IR vs modified release), previous use, sedation/respiratory depression risk, alcohol and benzodiazepine co-use, and real-time prescription monitoring obligations where applicable.
Counsel on constipation, driving impairment, secure storage, and not sharing.
Be alert to early supply requests, multiple prescribers, and clinical red flags for misuse or diversion — professional judgment and legal checks still apply.
Oral chemotherapy / other oral anticancer agents
Verify dose, cycle days, supportive medicines (antiemetics, supportive care), handling precautions, and toxicity return precautions (fever during neutropenia risk periods, uncontrolled vomiting, bleeding).
These are not “ordinary S4 scripts” in counselling intensity even when the logistics resemble community dispensing.
Shared high-risk process habits
Read the whole prescription and supporting notes.
Reconcile with known history and recent discharge summaries when available.
Use two-identifier patient checks.
Apply cautionary advisory labels and spoken counselling that match the real risk.
Know when to defer supply pending clarification.
Avoiding unnecessary medicines beyond antibiotics
Judicious use is broader than stewardship posters:
- Duplicate paracetamol from combination cold products
- Long-term proton pump inhibitors continued without indication review
- Sedating antihistamines for chronic insomnia without addressing cause
- Codeine-free but still inappropriate analgesic combinations stacked together
Requests to “cover” a viral illness with leftover antibacterials plus multiple symptom cocktail packs that exceed safe paracetamol limits
Ask: What problem is this medicine solving, for how long, and what harm might it add? If you cannot answer, reassess.
Putting it together in exam vignettes
A high-scoring approach usually looks like:
Clarify diagnosis likelihood (viral vs bacterial vs non-infectious).
Identify patient risks (age, pregnancy, immunosuppression, allergies, renal function).
Choose non-drug and symptomatic options first when appropriate.
If an antimicrobial prescription is present, verify fit for purpose; if an OTC request implies antibiotic expectation, educate and refer when needed.
For high-risk chronic agents, prioritise error-prevention checks and toxicity counselling over speed.
Document material interventions and communicate with prescribers when therapy looks unsafe or incomplete.
Judicious use is not withholding care. It is precision care : antibiotics when infection physiology and guidelines support them, and meticulous respect for medicines that can kill when processes fail.